Chimeric antigen receptor T-cell therapy — assessment and management of toxicities-Reference-Cited by-同舟云学术

Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

Published:2017-09-19 Issue:1 Volume:15 Page:47-62
ISSN:1759-4774
Container-title:Nature Reviews Clinical Oncology
language:en
Short-container-title:Nat Rev Clin Oncol

Author:

Neelapu Sattva S.,Tummala Sudhakar,Kebriaei Partow,Wierda William,Gutierrez Cristina,Locke Frederick L.,Komanduri Krishna V.,Lin Yi,Jain Nitin,Daver Naval,Westin Jason,Gulbis Alison M.,Loghin Monica E.,de Groot John F.,Adkins Sherry,Davis Suzanne E.,Rezvani Katayoun,Hwu Patrick,Shpall Elizabeth J.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://www.nature.com/articles/nrclinonc.2017.148.pdf

Reference98 articles.

1. Rosenberg, S. A. & Restifo, N. P. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348, 62–68 (2015).

2. June, C. H., Riddell, S. R. & Schumacher, T. N. Adoptive cellular therapy: a race to the finish line. Sci. Transl Med. 7, 280ps7 (2015).

3. Kochenderfer, J. N. et al. Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood 116, 4099–4102 (2010).

4. Porter, D. L., Levine, B. L., Kalos, M., Bagg, A. & June, C. H. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N. Engl. J. Med. 365, 725–733 (2011).

5. Grupp, S. A. et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N. Engl. J. Med. 368, 1509–1518 (2013).

Cited by 1733 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B cells enhance EphA2 chimeric antigen receptor T cells cytotoxicity against glioblastoma via improving persistence;Human Immunology;2024-11

2. CAR T-cell therapy in cancer: Integrating nursing perspectives for enhanced patient care;Asia-Pacific Journal of Oncology Nursing;2024-10

3. Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies;Blood;2024-09-12

4. Targeting cytokine networks in neuroinflammatory diseases;Nature Reviews Drug Discovery;2024-09-11

5. A 40-Year-Old Male Patient With Encephalopathy Hypertension And Emergency Hypertension With Sinus Tachycardia And Acute Kidney Injury. A Case Report.;Health & Medical Sciences;2024-09-10